Comparative study of the efficacy of CO2 and fraxel lasers in treatment of cutaneous leishmaniasis scars

Journal of Isfahan Medical School

Volumn 31, Issue 269 SPEC.ISSUE, 2014, Pages 2277-2284

  Nilforoushzadeh, Mohammad Ali ^a,b   Siadat, Amir Hossein ^b   Haftbaradaran, Elaheh ^b   Minaravesh, Mohammad ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Fraxel laser; Leishmaniasis scars; Treatment

Indexed keywords

CARBON DIOXIDE;

ADULT; ARTICLE; CARBON DIOXIDE LASER; CONTROLLED STUDY; HEALING; HUMAN; MAJOR CLINICAL STUDY; RANDOMIZED CONTROLLED TRIAL; SKIN LEISHMANIASIS; SKIN SCAR;

EID: 84901609103     PISSN: 10277595     EISSN: 1735854X     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Berman JD. Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years. Clin Infect Dis 1997; 24(4): 684-703.
2. th program report. UNDP/ world bank/ WHO special program for research and training disease (TDR). Geneva, Switzerland: WHO; 1995. p. 135-49.
3. Ardehali S, Rezaei H. Leishmania and leishmaniasis. Tehran, Iran: Iran University Press; 1985. p. 149-60. [In Persian].
4. Momeni A, Amin Javaheri M, Tajdidi M, Emamjomeh M. Theraputic and side effects of Glucantime in cutaneous leishmaniasis. Nabz 1993; 2: 5-10. [In Persian].
5. st ed. Philadelphia, PA: Saunders; 1996. p. 1163-70.
6. th ed. Maldenm, MA: Blackwell Science: 2004. p. 38-9, 42.
7. Dowlati Y. Cutaneous leishmaniasis: clinical aspect. Clin Dermatol 1996; 14(5): 425-31.
8. Nilforoushzade MA, Sadeghian G. Cutaneous leishmaniasis. Isfahan, Iran: Isfahan University of Medical Sciences; 2002. [In Persian].
9. Thakur CP, Sinha GP, Pandey AK, Barat D, Singh RK. Daily versus alternate-day regimen of amphotericin B in the treatment of kala-azar: a randomized comparison. Bull World Health Organ 1994; 72(6): 931-6.
10. 2 resurfacing: a preliminary clinical study. The American Journal of Cosmetic Surgery 2008; 25(2): 97-101.
11. Tanzi EL, Wanitphakdeedecha R, Alster TS. Fraxel laser indications and long-term followup. Aesthet Surg J 2008; 28(6): 675-8.
12. Alster TS, Tanzi EL, Lazarus M. The use of fractional laser photothermolysis for the treatment of atrophic scars. Dermatol Surg 2007; 33(3): 295-9.
13. Chrastil B, Glaich AS, Goldberg LH, Friedman PM. Second-generation 1,550-nm fractional photothermolysis for the treatment of acne scars. Dermatol Surg 2008; 34(10): 1327-32.
14. Nilforoushzadeh MA. Cutaneous leishmaniasis: treatment and prevention. Isfahan, Iran: Isfahan University of Medical Sciences; 1992. [In Persian].
15. Rivera AE. Acne scarring: a review and current treatment modalities. J Am Acad Dermatol 2008; 59(4): 659-76.
16. 2 laser in the treatment of cutaneous leishmaniasis scar. Iran J Dermatol 2007; 10(3): 181-6. [In Persian].
17. Biotech Week Publication. Reliant technologies announces FDA clearance of the fraxel(R) Laser for the treatment of acne and surgical scars; physicians report fractional laser resurfacing achieves dramatic improvement [Online] 2006. Available from: URL: http://www.cosmeticsurgerynews. com/article2829.html/
18. Lee HS, Lee JH, Ahn GY, Lee DH, Shin JW, Kim DH, et al. Fractional photothermolysis for the treatment of acne scars: a report of 27 Korean patients. J Dermatolog Treat 2008; 19(1): 45-9.
19. AlGhammdi Kh. Treatment of atrophic leishmania scars by fractional laser. Proceedings of the Laser International 2010 Medical Applications Conference; 2010 Jan 11-13; Riadh, Saudi Arabia.